These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 9695776)

  • 1. [Detection of chromosome translocation t(9;22) using RT-PCR].
    Sidorova ZhI; Bogdanov KV; Kapustin SI; Lyshchev AA; Marinets OV; Ogorodnikova IuS; Martynkevich IS; Sitskaia KO; Zubarovskaia LS; Zaritskiĭ AIu; Afanas'ev BV; Abdulkadyrov KM; Blinov MN
    Vopr Onkol; 1998; 44(3):300-3. PubMed ID: 9695776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative nested reverse transcriptase PCR vs. real-time PCR for measuring AML1/ETO (MTG8) transcripts.
    Takenokuchi M; Yasuda C; Takeuchi K; Nakamachi Y; Mukai M; Kondo S; Kumagai S; Saigo K; Murayama T; Koizumi T; Tatsumi E
    Clin Lab Haematol; 2004 Apr; 26(2):107-14. PubMed ID: 15053804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up.
    Papajík T; Jedlicková K; Kriegová E; Jarosová M; Raida L; Faber E; Hubácek J; Vondráková J; Pikalová Z; Indrák K
    Neoplasma; 2001; 48(6):501-5. PubMed ID: 11949845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of recurrent translocations using real time PCR; assessment of the technique for diagnosis and detection of minimal residual disease.
    Gabert J
    Haematologica; 1999 Jun; 84 Suppl EHA-4():107-9. PubMed ID: 10907485
    [No Abstract]   [Full Text] [Related]  

  • 5. Follicular lymphoma: quantitation of minimal residual disease by PCR of the t(14;18) translocation.
    Darby A; Gribben JG
    Methods Mol Med; 2005; 115():315-31. PubMed ID: 15998976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined polymerase chain reaction methods to detect c-myc/IgH rearrangement in childhood Burkitt's lymphoma for minimal residual disease analysis.
    Busch K; Borkhardt A; Wössmann W; Reiter A; Harbott J
    Haematologica; 2004 Jul; 89(7):818-25. PubMed ID: 15257933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring minimal residual disease in AML: the right time for real time.
    Jaeger U; Kainz B
    Ann Hematol; 2003 Mar; 82(3):139-47. PubMed ID: 12634945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of minimal residual disease in patients with t(15;17).
    Grimwade D
    Best Pract Res Clin Haematol; 2002 Mar; 15(1):137-58. PubMed ID: 11987921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations.
    Böttcher S; Ritgen M; Buske S; Gesk S; Klapper W; Hoster E; Hiddemann W; Unterhalt M; Dreyling M; Siebert R; Kneba M; Pott C;
    Haematologica; 2008 Apr; 93(4):551-9. PubMed ID: 18379010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection and diagnostic value of t(14;18) translocation in minimal residual disease of follicular lymphoma].
    Bessenyei B; Urbán L; Takács I; Zeher M; Szegedi G; Semsei I
    Orv Hetil; 2000 Jul; 141(31):1715-9. PubMed ID: 10976195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukemic stem cells in childhood high-risk ALL/t(9;22) and t(4;11) are present in primitive lymphoid-restricted CD34+CD19- cells.
    Hotfilder M; Röttgers S; Rosemann A; Schrauder A; Schrappe M; Pieters R; Jürgens H; Harbott J; Vormoor J
    Cancer Res; 2005 Feb; 65(4):1442-9. PubMed ID: 15735032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of DEK-CAN fusion transcript by real-time reverse transcription polymerase reaction in patients with t(6;9) acute myeloid leukemia.
    Tobal K; Frost L; Liu Yin JA
    Haematologica; 2004 Oct; 89(10):1267-9. PubMed ID: 15477217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined use of reverse transcriptase polymerase chain reaction and flow cytometry to study minimal residual disease in Philadelphia positive acute lymphoblastic leukemia.
    Muñoz L; López O; Martino R; Brunet S; Bellido M; Rubiol E; Sierra J; Nomdedéu JF
    Haematologica; 2000 Jul; 85(7):704-10. PubMed ID: 10897122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal residual disease in acute myeloid leukaemia.
    Liu Yin JA
    Best Pract Res Clin Haematol; 2002 Mar; 15(1):119-35. PubMed ID: 11987920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of minimal residual disease monitoring in acute myeloid leukemia patients with t(9;11)(p22;q23).
    Tobal K
    Haematologica; 2005 Dec; 90(12):1586A. PubMed ID: 16330423
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of different strategies of molecular genetic monitoring following autologous stem cell transplantation in patients with follicular lymphoma.
    von Neuhoff N; Dreger P; Suttorp M; Marget M; Kell S; Schmitz N
    Bone Marrow Transplant; 1998 Jul; 22(2):161-6. PubMed ID: 9707024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of minimal residual disease quantification by real-time reverse transcriptase polymerase chain reaction in patients with core binding factor leukemias.
    Krauter J; Gorlich K; Ottmann O; Lubbert M; Dohner H; Heit W; Kanz L; Ganser A; Heil G
    J Clin Oncol; 2003 Dec; 21(23):4413-22. PubMed ID: 14645432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Disappearance of residual disease confirmed by RT-PCR following induction chemotherapy in two hypoplastic leukemia patients with t(8;21)].
    Sawada M; Tsurumi H; Yamada T; Hara T; Oyama M; Moriwaki H
    Rinsho Ketsueki; 1999 Apr; 40(4):311-7. PubMed ID: 10355140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of various exon combinations of the ews/fli1 translocation: an optimized RT-PCR method for paraffin embedded tissue -- a report by the CWS-study group.
    Stegmaier S; Leuschner I; Aakcha-Rudel E; Münch P; Kazanowska B; Bekassy A; Treuner J; Koscielniak E
    Klin Padiatr; 2004; 216(6):315-22. PubMed ID: 15565546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-induction residual disease in translocation t(12;21)-positive childhood ALL.
    Seyfarth J; Madsen HO; Nyvold C; Ryder LP; Clausen N; Jonmundsson GK; Wesenberg F; Schmiegelow K
    Med Pediatr Oncol; 2003 Feb; 40(2):82-7. PubMed ID: 12461790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.